UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024408
Receipt number R000028010
Scientific Title Effect of enteral feeding by formula which contains Bifidobacteria in low birth weight infants
Date of disclosure of the study information 2019/12/31
Last modified on 2020/03/03 10:11:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of enteral feeding by formula which contains Bifidobacteria in low birth weight infants

Acronym

Bifidobacteria/LW study

Scientific Title

Effect of enteral feeding by formula which contains Bifidobacteria in low birth weight infants

Scientific Title:Acronym

Bifidobacteria/LW study

Region

Japan


Condition

Condition

Low birth weight infants

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the acceleration effect of enteral feeding and safety by formula which contains Bifidobacteria for LBWI

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

establishment of enteral feeding,defined as the postnatal day at which the amount of enteral feeding exceeded 100ml/kg/day

Key secondary outcomes

Growth(length,bodyweight, head circumference)
Blood examination(calcium, phosphorus,ALP,iron,albumin,BUN,Hb)
Morbidity(ricket,ROP,infection,anemin,NEC,CLD,PVL)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

The infants receive either breast milk or premature formula which contains Bifidobacteria(test formula) if the mothers have inadequate milk production.

The administration of test formula to each infant is continued until the body weight reached 2,000g.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

0 years-old <=

Age-upper limit

0 years-old >=

Gender

Male and Female

Key inclusion criteria

LBWI(birthweight:>=1,000g and <2,000g, gestational age:>=28weeks) who is born in Toho university Ohmori medical center

Parents receive enough information and consent to participate this trial


Key exclusion criteria

Who have sever respiratory ,renal ,cardiac or metabolic disease

Who have chromosomal disease, congenital malformations

Lack of parental consent

Who are desided inappropriate to participate this trial

Target sample size

45


Research contact person

Name of lead principal investigator

1st name Hiroko
Middle name
Last name Arai

Organization

Toho University Ohmori Medical Center

Division name

Department of Neonatology

Zip code

143-8541

Address

6-11-1,Ohmori-Nishi,Ohta-ku,Tokyo 143-8541,Japan

TEL

03-3762-4151

Email

araihiro@med.toho-u.ac.jp


Public contact

Name of contact person

1st name Hiroko
Middle name
Last name Arai

Organization

Toho University Ohmori Medical Center

Division name

Department of Neonatology

Zip code

143-8541

Address

6-11-1,Ohmori-Nishi,Ohta-ku,Tokyo 143-8541,Japan

TEL

03-3762-4151

Homepage URL


Email

araihiro@med.toho-u.ac.jp


Sponsor or person

Institute

Toho University Ohmori Medical Center
Department of Neonatology

Institute

Department

Personal name



Funding Source

Organization

Meiji co.,Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toho University Omori Medical Center

Address

6-11-1,Ohmori-Nishi,Ohta-ku,Tokyo 143-8541,Japan

Tel

0337624151

Email

araihiro@med.toho-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東邦大学医療センター大森病院


Other administrative information

Date of disclosure of the study information

2019 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2016 Year 07 Month 29 Day

Date of IRB

2016 Year 09 Month 28 Day

Anticipated trial start date

2016 Year 10 Month 24 Day

Last follow-up date

2018 Year 11 Month 30 Day

Date of closure to data entry

2019 Year 05 Month 31 Day

Date trial data considered complete

2019 Year 05 Month 31 Day

Date analysis concluded

2019 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 10 Month 14 Day

Last modified on

2020 Year 03 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028010


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name